Baud D, Greub G: Intracellular bacteria and adverse pregnancy outcomes. Clin Microbiol Infect 17: 1312, 2011
Beau AB, Hurault-Delarue C, Vial T, et al: Sfery of oseltamivir during pregnancy: a comparative study using the EFEMERIS database. BJOG 121(7):895,2014 Beigi RH: Emerging infectious diseases in pregnancy. Obstet Gynecol 129(5):896,t2017
Beigi RH, Bunge K, Song Y, et al: Epidemiologic and economic efects of methicillin-resistant Staphylococcus aureus in obstetrics. Obstet Gynecol 113:983, 2009
Beigi RH, Venkataramanan R, Caritis SN: Oseltamivir for inluenza in pregnancy. Semin PerinatoIt38(8):503, 2014
Bonvicini F, Puccetti C, Salfi NC, et al: Gestational and fetal outcomes in B19 matenal infection: a problem of diagnosis. J Clin MicrobioI49(10):3514, 201t1 Brasil P, Pereira JP, Moreira ME, et al: Zika virus infection in pregnant women in Rio de Janeiro. N Engl J Med 375(24):2321,t2016
Briody VA, Albright CM, Has P, et al: Use of cefazolin for group B streptococci prophylaxis in women reporting a penicillin allergy without anaphylaxis. Obstet Gynecol 7,t2016
Brown GC, Karunas RS: Relationship of congenital anomalies and maternal infection with selected enteroviruses. Am J Epidemiol 95:207, 1972
Brown E: Parvovirus infections. In Kasper DL, Fauci AS, Hauser SL, et al (eds): Harrison's Principles of Internal Medicine, 19th ed. New York, McGraw-Hill,t2015
Buchanan R, Bonthius DJ: Measles virus and associated central nervous system sequelae. Semin Pediatr ,t2012
Butterly A, Schmidt U, Wiener-Kronish J: Methicillin-resistant Staphylococcus aureus colonization, its relationship to nosocomial infection, and eicacy of control methods. Anesthesiology 113: 1453, 2010
Callaghan WM, Creanga A,Jamieson DJ: Pregnancy related mortality resulting from inluenza in the United States during the 2009-2010 pandemic. Obstet Gynecol 126(3):486,t2015
Centers for Disease Control and Prevention: Prevention of perinatal group B streptococci disease. Revised guidelines from the CDC. MvfWR 59(10):1, 20t10
Centers for Disease Control and Prevention: Maternal and infant outcomes among severely ill pregnant and postpartum women with 2009 pandemic influenza A (H1N1)-United States, April 2009-August 2010. MMWR 60(35):1193,t2011
Centers for Disease Control and Prevention: FDA approval of an extended period for administering VariZIG for postexposure prophylaxis of varicella. MMWR 61(12):212,t2012
Centers for Disease Control and Prevention: Prevention and control of seasonal inluenza with vaccines: recommendations of the Advisory Committee on Immunization Practices-United States, 2013-2014. MMWR 62(7):1, 2013a